Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Poly IC and Entecavir for Chronic Hepatitis B
NCT02532413Phase 4Unknown
- Start
- Jul 2015
- Primary completion
- Aug 2016
- Modality
- Antisense DNA, Small Interfering RNA (siRNA), Liposomes
- Countries
- 1
01
Overview
A Phase 4 trial of polyinosine-polycytidylic acid in Chronic Hepatitis B (CHB). Status: unknown.
02
Drugs
polyinosine-polycytidylic acid
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02532413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02532413.